Across TCGA pan-cancer cohorts, ANKRD49P4 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated ANKRD49P4 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ANKRD49P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ANKRD49P4 expression acts as an unfavorable survival marker.
BLCA, PAAD, and UCEC are the cancer types where ANKRD49P4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.